Skip to main content

Table 4 Mode of treatment (surgery or radiotherapy) for those who underwent radical treatment according to the Cambridge Prognostic Group (CPG)

From: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

 

Patients (n)

Surgery (%)

RT (%)

Adj. RR

95% CI

P

CPG

 1

1236

726 (58.7)

510 (41.3)

0.87

0.59–1.28

< 0.001

 2

6580

3691 (56.1)

2889 (43.9)

0.84

0.80–0.88

 

 3

6263

2488 (40.7)

3775 (59 .3)

0.99

0.92–1.08

 

 4

10,112

4133 (40.9)

5979 (59.1)

1

  

 5

11,118

2238 (20.1)

8880 (79.9)

1.26

1.12–1.40

 

Age group (years)

 < 60

5195

3916 (75.4)

1279 (24.6)

1

 

< 0.001

 60–69

14,843

7275 (49.0)

7568 (51.0)

1.97

1.68–2.30

 

 70–79

14,073

2081 (14.8)

11,992 (85.2)

3.17

2.54–3.95

 

 ≥ 80

1198

40 (0.3)

1194 (99.7)

3.52

2.84–4.37

 

Number of comorbidities (RCS Charlson score)

 0

27,921

11,120 (39.8)

16,801 (60.2)

1

 

0.081

 1

5159

1577 (30.6)

3582 (69.4)

1.09

1.01–1.18

 

 ≥ 2

2229

579 (26.0)

1650 (74.0)

1.12

0.99–1.27

 

Socioeconomic deprivation status (5th of national distribution)

 1 (least deprived)

8525

3387 (39.7)

5138 (60.3)

1

 

0.003

 2

8309

3068 (36.9)

5241 (63.1)

1.05

0.87–1.26

 

 3

7428

2771 (37.3)

4657 (62.7)

1.07

0.77–1.50

 

 4

6067

2244 (37.0)

3823 (63.0)

1.12

0.74–1.67

 

5 (most deprived)

4980

1806 (36.3)

3174 (63.7)

1.16

0.72–1.88

 

Ethnicity

 White

32,840

12,078 (36.8)

20,760 (63.2)

1

 

0.922

 Non-white

2469

1198 (48.5)

1273 (51.5)

0.94

0.29–3.08